Advertisement Kamada gets Israel patent for Ultrapure Transferrin - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Kamada gets Israel patent for Ultrapure Transferrin

Kamada has been awarded Israeli Patent for its Ultrapure Transferrin which is to be used in Pharmaceutical Compositions.

Transferrin, a protein found in human blood, binds to and transports iron in the bloodstream from and to cells.

Transferrin is also studied for pharmaceutical applications as a potential conjugate material (carrier) to a number of active molecules, including various chemotherapy drugs.

Kamada has recently received another patent under the same title after being granted with the same patent title by the US Patent Office (USPTO).